Bone-marrow transplantation for acute leukemia.
Bone-marrow transplantation for acute leukemia.
复制标题
骨髓移植治疗急性白血病。
DOI：
--
复制
发表时间：
1981
影响因子：
158.5
通讯作者：
J. Fahey
中科院分区：
文献类型：
--
作者：
K. Blume;W. Spruce;S. Forman;J. Wolf;M. Farbstein;E. Scott;J. Fahey
Between May 1976 and December 1983, 200 patients underwent bone marrow transplantation (BMT) for hematologic malignancies at our center; 164 had acute leukemia. After administration of high dose radiochemotherapy for marrow ablation and immunosuppression, these 164 patients received marrow grafts from histocompatible sibling donors. Graft-versus-host disease prophylaxis (and therapy) consisted of either methotrexate and prednisone or cyclosporin A and prednisone. All patients have been followed for a minimum of 3 months after BMT. Results are summarized in Table 1 and Fig. 1.
对第二次或随后缓解的急性淋巴细胞白血病患者进行强化治疗后进行骨髓移植：预后因素的确定（明尼苏达大学骨髓移植小组的报告）。
影响因子：
20.3
作者：
Woods,WG;Nesbit,ME;Ramsay,NK;Krivit,W;Kim,TH;Goldman,A;McGlave,PB;Kersey,JH
通讯作者：
Kersey,JH
影响因子：
158.5
作者：
SANTOS, GW;TUTSCHKA, PJ;YEAGER, AM
通讯作者：
YEAGER, AM